Compare DECK & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DECK | STE |
|---|---|---|
| Founded | 1973 | 1985 |
| Country | United States | United States |
| Employees | N/A | 3700 |
| Industry | Shoe Manufacturing | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4B | 21.6B |
| IPO Year | 1996 | 2018 |
| Metric | DECK | STE |
|---|---|---|
| Price | $88.86 | $235.85 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 23 | 5 |
| Target Price | $122.45 | ★ $275.20 |
| AVG Volume (30 Days) | ★ 2.3M | 715.0K |
| Earning Date | 05-21-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 1.19% |
| EPS Growth | 10.90 | ★ 27.90 |
| EPS | 0.94 | ★ 7.93 |
| Revenue | $5,472,296,000.00 | ★ $5,935,900,000.00 |
| Revenue This Year | $11.16 | $9.88 |
| Revenue Next Year | $6.96 | $6.32 |
| P/E Ratio | $97.41 | ★ $29.88 |
| Revenue Growth | ★ 9.76 | 8.73 |
| 52 Week Low | $78.91 | $195.14 |
| 52 Week High | $125.45 | $269.44 |
| Indicator | DECK | STE |
|---|---|---|
| Relative Strength Index (RSI) | 34.26 | 60.73 |
| Support Level | N/A | $211.06 |
| Resistance Level | $105.61 | $238.53 |
| Average True Range (ATR) | 2.44 | 5.82 |
| MACD | -0.58 | -0.47 |
| Stochastic Oscillator | 6.35 | 81.82 |
Founded in 1973, California-based Deckers designs and sells casual and performance footwear, apparel, and accessories. In fiscal 2026, Ugg and Hoka accounted for 50% and 47% of total sales, respectively. The firm also markets a niche sandal brand Teva. Deckers produces most of its sales through wholesale partnerships but also operates e-commerce in more than 50 countries and has more than 200 company-operated stores, about half of which are outlets. The firm generated 58% of its fiscal 2026 sales in the United States.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.